Posts tagged Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.
Blogs
less than a minute
On March 16, 2020, FDA finalized its guidance titled Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency (the “Policy”). The Policy includes information and recommendations to assist laboratories and commercial manufacturers in development of diagnostic tests for the novel coronavirus (“COVID-19”) during the ongoing pandemic.
During the first week of implementation, questions arose regarding the extent to which the Emergency Use Authorization (“EUA”) pathway to market, as described by the Policy, covers at-home ...
Blog Editors
Recent Updates
- What Health Care Lawyers and Professionals Need to Know About Emerging Employee Benefit Issues
- A Final Rule Bites the Dust, Part II: FDA Gives up on Regulating LDTs as Medical Devices
- Oregon SB 951, Regulating the Corporate Practice of Medicine, Awaits Governor’s Signature
- DOJ Civil Rights Fraud Initiative: FCA Enforcement Expanding Into Alleged Discrimination
- Utah Law Aims to Regulate AI Mental Health Chatbots